| CXHL1900207 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2019-06-24 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2019-06-21 | view |
| CXHB2000015 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs | Supplementary Application | 2020-03-17 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-03-16 | view |
| CXHB1500038 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs | Supplementary Application | 2015-05-25 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2016-03-17 | view |
| CXHB2000096 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2020-09-30 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-09-30 | view |
| CXHS1700014 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(1) | New Drug Application | 2017-08-24 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2018-08-17 | view |
| CXHL1900299 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2019-09-19 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2019-09-18 | view |
| CXHL1100290 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(1.1) | New Drug Application | 2011-05-27 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2012-05-23 | view |
| CXHL2000310 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2020-07-04 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-07-02 | view |
| CXHB1600050 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs | Supplementary Application | 2016-09-19 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2017-03-29 | view |
| CXHB2000014 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs | Supplementary Application | 2020-03-17 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-03-16 | view |
| CXHB1500039 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs | Supplementary Application | 2015-05-25 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2016-03-17 | view |
| CXHB2000076 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2020-08-27 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-08-25 | view |
| CXHS1700013 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(1) | New Drug Application | 2017-08-24 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2018-08-17 | view |
| CXHL1900300 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2019-09-19 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2019-09-18 | view |
| CXHL2000311 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2020-07-04 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-07-02 | view |
| CXHB1500044 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs | Supplementary Application | 2015-05-25 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2015-12-02 | view |
| CXHB2100044 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-03-20 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2021-03-19 | view |
| CXHL1900208 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | New Drug Application | 2019-06-24 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2019-06-21 | view |
| CXHL1100291 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(1.1) | New Drug Application | 2011-05-27 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | Certificate Issued | 2012-05-23 | view |
| CXHB2000075 | 马来酸吡咯替尼片 | pyrotinib maleate | Tablet | Chemical Drugs(2.4) | Supplementary Application | 2020-08-27 | 江苏恒瑞医药股份有限公司 | Jiangsu Hengrui Pharmaceuticals Co Ltd | In Review | 2020-08-25 | view |
